
Non-replicating viral vector vaccines and the Belgian vaccination strategy against COVID-19
In this opinion, the Belgian Health Council revised its recommendations concerning the administration of the vaccine "COVID-19 Vaccine AstraZeneca®" on the basis of the most recent scientific knowledge and data.
(For now, only available in Dutch or French)
-
Advies 9626 - Vaccinatie Covid-19 VVNRep
Nederlands20210311_hgr-9626_vvnrep-leeftijd-comorbiditeiten-astrazeneca_vweb.pdf PDF document - 2.06 MB
-
Avis 9626 - Vaccination Covid-19 VVNRep
Frans20210311_css-9626_vvnrep-age-comorbidites-astrazeneca_vweb.pdf PDF document - 2.07 MB
-
-